- Gemtuzumab ozogamicin2020 | Third Faculty of Medicine
- Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study2010 | Second Faculty of Medicine
- Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Munster study group2019 | Second Faculty of Medicine
- Biological drugs in hematooncology2012 | First Faculty of Medicine
- Correlation of CD33 with poorer prognosis in childhood ALL implicates a potential of anti-CD33 frontline therapy2005 | Second Faculty of Medicine
- Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation2018 | Second Faculty of Medicine
- The Relapsed AML 2001/01, 02 Study for children with relapsed acute myeloid leukaemia or initially resistent disease has improved outcome2011 | First Faculty of Medicine
- The relapsed AML 2001/01, 02 study for children with relapsed acute myeloid leukaemia or initially resistant disease has improved outcome2011 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport